Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XRP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 for Stelara 90 mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. This award represents a continuation of DMS Pharmaceutical Group's significant role as a supplier within the federal pharmaceutical supply chain, leveraging its expertise in distributing specialty pharmaceutical products to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The underlying IDC enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across military health facilities worldwide. Stelara is a specialty biologic medication used in the treatment of various autoimmune and inflammatory conditions, reflecting the contractor's established capability in supplying high-value specialty pharmaceutical products to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6XRP?
SPE2DX25F6XRP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25F6XRP worth?
The government has obligated $16,250 on SPE2DX25F6XRP.
Is contract SPE2DX25F6XRP an order under another contract?
Yes. SPE2DX25F6XRP is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRP competed?
The extent of competition for SPE2DX25F6XRP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award